Abstract
Trichophyton rubrum is a good model for the study of human pathogenic filamentous fungi. The antifungal agent terbinafine (TRB) shows specific activity against T. rubrum. To identify the transcriptional profiles of response to TRB in T. rubrum, a cDNA microarray was constructed from the expressed sequence tags of different phase cDNA libraries and transcriptional profiles of the response to TRB were determined. Exposure to TRB decreased the transcription of some genes involved in the ergosterol biosynthesis pathway, including ERG2, ERG4, ERG24, and ERG25, and induced the expression of some genes involved in lipid metabolism such as ERG10, ERG13, and INO1. TRB affected transcription of multidrug-resistance genes and some genes encoding ribosomal proteins.
Similar content being viewed by others
References
Aly R, Forney R, Bayles C (2001) Treatments for common superficial fungal infections. Dermatol Nurs 13:91–101
Bammert GF, Fostel JM (2000) Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 44:1255–1265
Casey WM, Keesler GA, Parks LW (1992) Regulation of partitioned sterol biosynthesis in Saccharomyces cerevisiae. J Bacteriol 174:7283–7288
Chen BK, Friedlander SF (2001) Tinea capitis update: a continuing conflict with an old adversary. Curr Opin Pediatr 13:331–335
Cleveland WS (1979) Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74:829–836
Coloe SV, Baird RW (1999) Dermatophyte infections in Melbourne: trends from 1961/64 to 1995/96. Pathology 31:395–397
Costa M, Passos XS, Souza LK, Miranda AT, Lemos JA, Oliveira JG, Silva MR (2002) Epidemiology and etiology of dermatophytosis in Goiania, GO. Brazil Rev Soc Bras Med Trop 35:19–22
Crawford F, Young P, Godfrey C, Bell-Syer SE, Hart R, Brunt E, Russell I (2002) Oral treatments for toenail onychomycosis: a systematic review. Arc Dermatol 138:811–816
De Backer MD, Ilyina T, Ma XJ, Vandoninck S, Luyten WH, Vanden Bossche H (2001) Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 45:1660–1670
De Hoog GS, Guarro J, Gene J, Figueras MJ (2000) Atlas of Clinical Fungi, 2nd Ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands and University Rovirai Virgili, Reus, Spain
Degreef HJ, DeDoncker PR (1994) Current therapy of dermatophytosis. J Am Acad Dermatol 31:S25–S30
Diehl F, Grahlmann S, Beier M, Hoheisel JD (2001) Manufacturing DNA-microarrays of high spot homogeneity and reduced background signal. Nucleic Acids Res 29:e38
Elewski BE, Leyden J, Rinaldi MG, Atillasoy E (2002) Office practice-based confirmation of onychomycosis: a U.S. nationwide prospective survey. Arch Intern Med 162:2133–2138
Fachin AL, Ferreira-Nozawa MS, Maccheroni W, Martinez-Rossi NM (2006) Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum. J Med Microbiol 55:1093–1099
Favre B, Ryder NS (1996) Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents. Antimicrob Agents Chemother 40:443–447
Favre B, Ryder NS (1997) Cloning and expression of squalene epoxidase from pathogenic yeast Candida albicans. Gene 189:119–126
Gupta AK, Shear NH (1997) Terbinafine: an update. J Am Acad Dermatol 37:979–988
Jackson CJ, Barton RC, Evans EGV (1999) Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol 37:931–936
Jennings MB, Weinberg JM, Koestenblatt EK, Lesczczynski C (2002) Study of clinically suspected onychomycosis in a podiatric population. J Am Podiat Med Assoc 92:327–330
Jessup CJ, Ryder NS, Ghannoum MA (2000) An evaluation of the in vitro activity of terbinafine. Med Mycol 38:155–159
Klobucnikova V, Kohut P, Leber R, Fuchsbichler S, Schweighofer N, Turnowsky F, Hapala I (2003) Terbinafine resistance in a pleiotropic yeast mutant is caused by a single point mutation in the ERG1 gene. Biochem Biophys Res Commun 309:666–671
Kulkarni RD, Kelkar HS, Dean RA (2003) An eight-cysteine-containing CFEM domain unique to a group of fungal membrane proteins. Trends Biochem Sci 28:118–121
Larone DH (2002) Medically important fungi: a guide to identification, 4th ed. American Society for Microbiology, Washington, DC
Leber R, Fuchsbichler S, Klobucnikova V, Schweighofer N, Pitters E, Wohlfarter K, Lederer M, Landl K, Ruckenstuhl C, Hapala I, Turnowsky F (2003) Molecular mechanism of terbinafine resistance in S. cerevisiae. Antimicrob Agents Chemother 47:3890–3900
Leber R, Landl K, Zinser E, Ahorn H, Spök A, Kohlwein SD, Turnowsky F, Daum G (1998) Dual localization of squalene epoxidase, Erg1p, in yeast reflects a relationship between the endoplasmic reticulum and lipid particles. Mol Biol Cell 9:375–386
Leber R, Zenz R, Schröttner K, Fuchsbichler S, Pühringer B, Turnowsky F (2001) A novel sequence element is involved in the transcriptional regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces cerevisiae. Eur J Biochem 268:914–924
Leber R, Zinser E, Hrastnik C, Paltauf F, Daum G (1995) Export of steryl esters from lipid particles and release of free sterols in the yeast, Saccharomyces cerevisiae. Biochim Biophys Acta 1234:119–126
Lupetti A, Danesi R, Campa M, Del Tacca M, Kelly S (2002) Molecular basis of resistance to azole antifungals. Trends Mol Med 8:76–81
Monod M, Jaccoud S, Zaugg C, Lechenn B, Baudraz F, Panizzon R (2002) Survey of dermatophyte infections in the Lausanne area (Switzerland). Dermatology 205:201–203
Mukherjee PK, Leidich SD, Isham N, Leitner I, Ryder NS, Ghannoum MZ (2003) Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother 47:82–86
Paltauf F, Daum G, Zuder G, Högenauer G, Schulz G, Seidl G (1982) Squalene and ergosterol biosynthesis in fungi treated with naftifine, a new antimycotic agent. Biochim Biophys Acta 712:268–273
Parks LW, Casey WM (1995) Physiological implications of sterol biosynthesis in yeast. Annu Rev Microbiol 49:95–116
Pasrija R, Krishnamurthy S, Prasad T, Ernst JF, Prasad R (2005) Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J Antimicrob Chemother 55:905–913
Paulsen IT, Brown MH, Skurray RA (1996) Proton-dependent multidrug efflux systems. Microbiol Rev 60:575–608
Peng J, Zhang X, Yang J, Wang J, Yang E, Bin W, Wei C, Sun M, Jin Q (2006) The use of comparative genomic hybridization to characterize genome dynamics and diversity among the serotypes of Shigella. BMC genomics 7:218
Petranyi G, Meingassner JG, Mieth H (1987) Activity of terbinafine in experimental fungal infections of laboratory animals. Antimicrob Agents Chemother 31:1558–1561
Pinto WJ, Lozano R, Nes WR (1985) Inhibition of sterol biosynthesis by ergosterol and cholesterol in Saccharomyces cerevisiae. Biochim Biophys Acta 836:89–95
Ryder NS (1992) Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 126(Suppl. 39):2–7
Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378
Servouse M, Karst F (1986) Regulation of early enzymes of ergosterol biosynthesis in Saccharomyces cerevisiae. Biochem J 240:541–547
Smith SJ, Crowley JH, Park SLW (1996) Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae. Mol Cell Biol 16:5427–5432
Tsai HF, Bard M, Izumikawa K, Krol AA, Sturm AM, Culbertson NT, Pierson CA, Bennett JE (2004) Candida glabrata mutant with increased sensitivity to azoles and to low oxygen tension. Antimicrob Agents Chemother 48:2483–2489
Urban M, Bhargava T, Hamer JE (1999) An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease. EMBO J 18:512–521
Vanden Bossche H, Willemsens G, Marichal P (1987) Anti-Candida drugs—the biochemical basis for their activity. Clin Microbiol Rev 15:57–72
Vander Straten MR, Hossain MA, Ghannoum MA (2003) Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor. Infect Dis Clin North Am 17:87–112
Wang L, Ma L, Leng W, Liu T, Yu L, Yang J, Yang L, Zhang W, Zhang Q, Dong J, Xue Y, Zhu Y, Xu X, Wan Z, Ding G, Yu F, Tu K, Li Y, Li R, Shen Y, Jin Q (2006) Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags. BMC Genomics 7:255
Yu L, Zhang W, Wang L, Yang J, Liu T, Peng J, Leng W, Chen L, Li R, Jin Q (2007) Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum. Antimicrob Agents Chemother 51:144–153
Zhang L, Zhang Y, Zhou Y, An S, Zhou Y, Cheng J (2002) Response of gene expression in Saccharomyces cerevisiae to amphotericin B and nystatin measured by microarrays. J Antimicrob Chemother 49:905–915
Zhang W, Yu L, Leng W, Wang X, Wang L, Deng X, Yang J, Liu T, Peng J, Wang J, Li S, Jin Q (2007) cDNA microarray analysis of the expression profiles of Trichophyton rubrum in response to novel synthetic fatty acid synthase inhibitor PHS11A. Fungal Genet Biol 4:1252–1261
Acknowledgments
We are grateful to Ruoyu Li (Research Center for Medical Mycology, Peking University) for providing strain T. rubrum BMU 01672 and for helpful discussions. Financial supports for this work came from the National High Technology Research and Development Program of China (accession number 2006AA020504) and National Key Technologies R&D Programme (accession number 2002BA711A14).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table S1
(XLS 95.0 kb)
Rights and permissions
About this article
Cite this article
Zhang, W., Yu, L., Yang, J. et al. Transcriptional profiles of response to terbinafine in Trichophyton rubrum . Appl Microbiol Biotechnol 82, 1123–1130 (2009). https://doi.org/10.1007/s00253-009-1908-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-009-1908-9